Cardinal Health has announced the date of new board member Carrie Cox.
Ms Cox will begin her position on the board right away, the organisation exposed.
She has before taken such posts as executive vice-president and president of global pharmaceuticals at Schering-Plough and president of Pharmacia’s global pharmaceutical company.
Subsequent to the end of Schering-Plough’s merger with Merck in November, Ms Cox’s contract with the past corporation came to an end.
George Barrett, chairman and chief executive officer of Cardinal Health, believed that the firm is “excited” to be welcoming Ms Cox and her knowledge to the company.
“Carrie brings an extraordinary range of experiences from her 30 years in biopharmaceuticals and healthcare,” he said.
